Galectin Therapeutics Inc. (NASDAQ:GALT) will present at the Jefferies 2014 Global Healthcare Conference in New York City. Galectin Therapeutics Inc. (NASDAQ:GALT) stock performance was 3.20% in last session and finished the day at $13.22. Traded volume was 165.10K shares in the last session and the average volume of the stock remained 417.97K shares. The beta of the stock remained 1.62. Galectin Therapeutics Inc. (NASDAQ:GALT) insider ownership is 18.70%.

Sagent Pharmaceuticals Inc (NASDAQ:SGNT) Director Robert Flanagan unloaded 8,000 shares of the company’s stock in a transaction dated Thursday, May 22nd. The shares were sold at an average price of $22.02, for a total value of $176,160.00. Following the sale, the director now directly owns 6,996 shares of the company’s stock, valued at approximately $154,052. Sagent Pharmaceuticals Inc (NASDAQ:SGNT) dropped -1.16 percent to $22.19 Tuesday on volume of 151.30K shares. The intra-day range of the stock was $21.45 to $22.45. Sagent Pharmaceuticals Inc (NASDAQ:SGNT) has a market capitalization of $353.25million.

Unlike popular microblogging services such as Sina Corp’s Sina Weibo Corp (ADR) (NASDAQ:WB), where messages can reach millions of people in minutes, WeChat allows users to communicate in small, private circles of friends, and send text and voice messages for free – a big part of its success. Weibo Corp (ADR) (NASDAQ:WB)’s stock on June 03, 2014 reported a decrease of -0.16% to the closing price of $18.32. Its fifty two weeks range is $16.26 -$24.48. The total market capitalization recorded $5.83billion. The overall volume in the last trading session was 380.10K shares. In its share capital, WB has 202.68million outstanding shares.

Qihoo 360 Technology Co Ltd (NYSE:QIHU) on May 27 reported its unaudited financial results for the first quarter ended March 31, 2014. The company’s first quarter 2014 revenues were $265.1 million, representing an increase of 141.3% from $109.9 million in the first quarter of 2013 and an increase of 19.6% from $221.6 million in the fourth quarter of 2013. Net income was $49.1 million, compared to $5.6 million in the first quarter of 2013 and $16.7 million in the prior quarter. Non-GAAP net income was $73.3 million, compared to $17.5 million in the first quarter of 2013 and $96.3 million in the prior quarter. On Tuesday, shares of Qihoo 360 Technology Co Ltd (NYSE:QIHU) dropped -2.27% to close the day at $85.86. Company return on investment (ROI) is 5.50% and its monthly performance is recorded as -2.85%. Qihoo 360 Technology Co Ltd (NYSE:QIHU) quarterly revenue growth is -26.05%.